The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments
BMC Medicine 2015, 13:198 (20 August 2015)
In a mathematical model, post-treatment vaccination for hepatitis C virus (HCV) reduces disease prevalence more than treatment alone, even with a low-efficacy vaccine, suggesting that vaccination could contribute to HCV elimination efforts.
Managing HIV/hepatitis C co-infection in the era of direct acting antivirals
BMC Medicine 2013, 11:234 (1 November 2013)
This article is part of a collection on
HIV thirty years on
Jürgen Rockstroh and Sanjay Bhagani review new treatment strategies for HIV and hepatitis C co-infection, which allow shorter treatment duration and improved tolerability, and discuss the challenges associated with drug interactions.